Archive
Proactive news snapshot: Green Dragon Gas, Ergomed, IXICO …
A glance at some of the day's highlights from the Proactive Investors newswire
Company
Ergomed PLC
LON:ERGO
Ergomed PLC provides specialist services to the pharmaceutical industry spanning all phases of clinical development, post-approval pharmacovigilance and medical information. The company's fast-growing services business includes an industry-leading suite of specialist pharmacovigilance (PV) solutions, integrated under the PrimeVigilance brand and a full range of high-quality clinical research and trial management services under the Ergomed brand (CRO).
204 stories · page 2 of 3
Petra Diamonds' shares sparkle after Tanzania lifts export ban
The government of Tanzania has given Petra the go-ahead to resume diamond exports and sales from the Williamson mine.
Ergomed unveils €5.7mln acquisition of Dutch-based PSR Group, part-funded by £2.9mln placing
The company completed the placing this morning, after an accelerated bookbuild, with 1.757576mln new ordinary shares issued at a price of 165p each
FTSE 100 closes up but optimism not "particularly high"
FTSE 100 ended in positive territory, having been lower earlier,..
Archive
Proactive news snapshot: Ergomed , PCF Group, Synairgen …
A glance at some of the day's highlights from the Proactive Investors newswire
Imaginatik lifted by contract win with US investment management company
"We continue to believe that in order for an organisation to build and sustain a business-critical innovation ethos and competency, technology and consultancy need to be implemented in a joined-up way," said Imaginatik
Ergomed signs first commercialisation deal for its blood coagulant products
The deal has been driven by British innovation in the treatment of surgical bleeding with multi-million dollar potential, Ergomed said
FTSE 100 steadily extends gains
There has been no news flow from FTSE 100 companies to speak of today
Archive
Proactive news snapshot: Jersey Oil & Gas, Flying Brands, Itaconix …
A glance at some of the day's highlights from the Proactive Investors newswire
Ergomed pleased with top-line growth in "solid first half"
Drug safety monitoring and medical information services are set for a year of out-performance
Archive
Focus shifts to US interest rates with Fed meeting; UK retail updates due from Kingfisher, Ocado
Week ahead includes Federal Reserve interest rate announcement, UK retail sales data, second quarter results from Kingfisher PLC, and trading update from Ocado PLC
New float Destiny Pharma's shares race to a 30% debut premium
The company, only the second biotech float this year, is bringing through a next-generation antibiotic
FDA gives Ergomed’s partner green light to resume phase III cancer study
The FDA placed a partial clinical hold on the trial back in September citing issues over the study’s design and safety
Archive
Proactive news snapshot: Rose Petroleum, CentralNic, Falcon Media House...
Some of today's headlines on the Proactive newswire
Ergomed completes recruitment for phase IIb study of PeproStat ahead of schedule
The drug development and pharma services company expects to report top line data from its study of PeproStat in the fourth quarter
Archive
Proactive end of day round-up: Cadence Minerals, Sound Energy, Brave Bison...
A summary of stories on the Proactive newswire today
Ergomed trial of blood thickener on the fast-track
Having reached the recruitment mid-point for coagulant PeproStat, it expects to deliver the first data from the study by the fourth-quarter of this year, rather than in the first three months of 2018
FTSE 100 closes in red as financial stocks hit
The index of blue-chip shares closed down 24.92 at 7,447
Archive
Proactive end of day round-up: Be Heard, BOS Global Holdings, Sirius Minerals...
A glance at some of the main stories on the Proactive newswire today
Greka Drilling in demand as ONGC commits to drill programme
Risers & fallers: Record PLC pays out bumper dividends, EU Supply gets contract boost
Ergomed appoints new chief executive
Dr Dan Weng joins on July 1 from EPS Holdings, a Tokyo-listed contract research business
Archive
Proactive news summary: TekCapital, Nanobiotix , Ergomed ...
A summary of small cap news stories on the Proactive wires today
Ergomed notes Aeterna Zentaris drug trial results
“Success for Ergomed does not hinge on just one asset, but rather the overall potential of a diversified development pipeline."
Archive
Proactive news round-up: Ferrum Crescent, Gfinity, Blue Prism Group …
A glance at some of the stories on the Proactive newswire today
Investments and investor services
Gfinity pulls away fast from the grid
Ferrum Crescent jumps on news that drilling is about to kick off and Gfinity gets a turbo-boost from a hook-up with Microsoft.
Boardroom reshuffle at Ergomed
Jan Petracek will fill the void left by Neil Clark, chief executive of Ergomed’s PrimeVigilance subsidiary, who is moving to Destiny Pharma
Investments and investor services
FTSE 100 closes 21 points down ahead of Easter weekend
Yesterday the FTSE 100 briefly rose above 7,400 ... today, a sub-7,300 level beckons
Archive
Proactive news round-up: Solo Oil, UK Oil & Gas, AdEPT Telecom ...
A glance at some of the stories on the Proactive newswire today
Ergomed chairman buys 100,000 shares
The purchase takes Peter George stake in the company up to 0.6%.
Archive
Proactive news round-up: AFC Energy, Telit Communications, Brave Bison ...
A glance at some of the stories on the Proactive newswire today
ProPhotonix rallies while Juridica Investments and Altyn slump
Some of the largest rises and falls in London at 4pm: ProPhotonix, WS Atkins, Altyn, Imagination Tech
Drug research specialist Ergomed ready to push ahead with collaboration
Denmark-based Asarina Pharma is pioneering a treatment called Sepranolone for a severe and disabling form of premenstrual syndrome
Investments and investor services
FTSE 100 finishes lower as Dow Jones plunges
Since the manufacturing index reached a two-and-a-half-year high last December, the story has been one of a gentle decline - Martin Beck, senior economic advisor to the EY ITEM Club
Archive
Proactive news round-up: Sirius Minerals, CloudTag, Sound Energy ...
A glance at some of the stories on the Proactive newswire today
Ergomed revenues rise by almost a third as drug monitoring powers on
Pharmavigilance checks on the performance of drugs once they have been launched
Archive
Brexit and terrorism concerns in focus as Thomas Cook reports trading update
Thomas Cook posts a trading update tomorrow as the European travel industry continues to face challenging trading conditions
Falcon Oil surges on hint over Aussie gas drilling
Main share price risers and fallers in London around 3.30pm include Falcon Oil, Cap-XX
Drug developer Ergomed set to kick off phase II trial on treatment for surgical bleeding
Sales of PeproStat can be as high as US$500mln believes Ergomed
Investments and investor services
FTSE 100 ends little changed as UK lines up on Brexit grid
The druggies and miners were on offer early on – although the movements were barely perceptible on a lacklustre Monday morning.
Archive
Proactive news round-up: Ithaca Energy, Ergomed, Amryt Pharmaceuticals ...
A glance at some of the stories on the Proactive newswire today.
Ergomed announces positive top-line results from Phase II insomnia treatment trial
The group said the drug Lorediplon met the primary endpoint with high statistical significance, indicating the drug has “strong efficacy in sleep maintainance".
Ergomed expects 'pivotal ' endometrial cancer trial result in April
Ergomed's clinical services arm carried out the trial
Archive
Proactive news highlights: DekelOil, dotDigital, FairFX and more…
DekelOil confirms maiden dividend; dotDigital sees big pick-up in client spending; FairFX Group says 2016 revenues are ahead of expectations; plus much more…
Ergomed predicts more to come as revenues surge
Revenues in 2016 were £38mln, up 26%, with an order backlog at the end of the year of £70mln.
Archive
Proactive news round-up: Sound Energy, Matals Exploration, Acal ...
A snapshot of the stories on the Proactive newswire today
Proactive news round-up: Strategic Minerals, CloudTag, Frontier IP...
A round-up of today's small cap stories on the Proactive newswire
Ergomed names new chairman designate
Peter George has become chairman designate with immediate effect at Ergomed Plc (LON:ERGO) after Rolf Stahel notified the board he would retire at the expiry of his three year term on March 31 next year.
Immupharma among the small cap pharmas in focus on Wednesday
Immupharma among the small cap pharmas in focus on Wednesday, alongside Futura Medical, Horizon Discovery Group, and Summit Therapeutics.
Ergomed welcomes expansion of Sickle Cell Disease study
Modus Therapeutics, Ergomed's co-development partner on sevuparin, a treatment for Sickle Cell Disease, has been given the all-clear to also enrol teenagers into its clinical study.
Archive
Brokers: UK pharma giants in good shape if Clinton wins says Citigroup
“From a legislative angle, we continue to prefer names with either limited part D exposure [US Medicare] or heavier contribution of non-pharma assets."
Ergomed racing away with development pipeline
The trial is expected to start in 2017 and estimated to last around two years.
Ergomed to team up with Asarina Pharma in phase IIb trial
Ergomed will run and partly fund the phase IIb trial of Asarina’s premenstrual syndrome treatment Sepranolone in return for an equity stake in the firm
Small Cap highlights: Sareum leads Monday’s stand-out small cap biotech stocks
Sareum, Faron, WideCells, Abzena and Ergomed were among Monday's small cap highlights
Ergomed’s partner Modus Therapeautics set for stock market IPO
Ergomed co-invests in the trial in return for equity in the partner, and as a result it is a shareholder in the soon-to-list company.
Proactive news round-up: Nostra Terra, Aureus Mining, ITM Power...
A round-up of today's news on the Proactive newswire
Ergomed celebrates fourth licensing deal for anti-cancer compound
Ergomed jointly developed Zoptrex with AEterna Zentaris
Ergomed upbeat as drug safety arm powers ahead
Miroslav Reljanovic, chief executive, said it had been an excellent first half.
Ergomed picks up €1.5mln contract through German acquisitions
The contract is worth €1.5mln and covers six countries.
Ergomed - German research house starts coverage with 'buy'
GBC says its predicted growth stems from the group's 'solid' positioning in the market
Ergomed completes recruitment for insomnia drug trial
The firm is developing the drug with partner Ferrer and has now attained 130 patients from 11 clinical sites across three European countries..
Ergomed secures two new licensing deals for cancer compound
The two agreements follow the 2014 license agreement with Sinopharm A-Think Pharmaceuticals Co.
Archive
Proactive news highlights: FairFX, Allergy Therapeutics, SalvaRx, Akers Biosciences, GW Pharma & more
Low-cost currency provider FairFX enjoyed its best ever week last week thanks to heightened trading activity amid the UK’s EU referendum vote.
Ergomed unit Prime Vigilance opening the doors in Boston
The expansion reflects the demand for PrimeVigilance’s services Stateside.
Ergomed strengthens services business with two bolt-ons
O+P will complement the existing European CRO (contract research) network while GASD will become the centre of excellence for data management
Proactive news highlights: Cello, Ergomed, ITM Power, KEFI Minerals, Metminco and more...
Rambler Metals and Mining commences a prefeasibility in Newfoundland, ITM Power hits the road and Union Jack expects more acquisitions.
Ergomed snaps up bleed halting specialist
Ergomed will pay an initial consideration of £8mln with milestone and sales based payments of up to £20mln
Archive
Proactive news highlights: Breedon Aggregates, Ergomed, Mariana Resources ...
Strong order pipeline for Ergomed, Breedon Aggregates plans to address concerns and Mariana Resources withdraws from its Suriname gold project.
Ergomed's hybrid strategy gives it plenty of ammo
The hybrid pharma services and drug development group has hit some key milestones over this year as trial results are eyed.
Ergomed has booked 85% of this year's revenues already
Turnover for the year to December 31 rose 43% to £30.2mln, while underlying earnings (EBITDA) were up 39% at £3.4mln.
Tuesday's agenda: UK to drive top-line growth at ASOS
The UK is still driving sales growth for ASOS, though Europe remains a key focus
Week ahead - ASOS, Ergomed and Optibiotix Health among AIM stocks reporting
There's a flurry of interesting small cap firms reporting this week, alongside AIM internet retail biggie ASOS....
Archive
Brokers: Kurdistan lift for Genel, Gulf Keystone says Barclays
Genel. Gulf Keystone, Just Eat, Premier Oil, Ergomed...
Ergomed eyes more drug deals as revenues rise
Turnover rose 25% and orders at the year-end were approximately £59mln.
Ergomed takes on former Shire man in finance role
Stephen Stamp was group finance director at serviced office group Regus and finance director at pharma major Shire in previous jobs.
Investments and investor services
Proactive news highlights: MX Oil, W Resources, Alecto Minerals, Metal Tiger and more...
African Potash, Sound Energy and Tungsten Corp also had news out on Wednesday
Archive
Proactive small cap news highlights - Asiamet, Metminco, Trinity Exploration, Sound Energy, SacOil, Oilex, Photo-Me, Globo & others
Asiamet saw a resource upgrade, Metminco got a boost in its partnering efforts and Sound Energy's teamed up with Schlumberger
UPDATE - Ergomed unfazed by cancer trial end
It will not invest or participate in four other ongoing studies for the compound.
Investments and investor services
Proactive news highlights including Gfinity, Cohort, Motif Bio, Ergomed, Tern, dotDigital and more
A number of tech and mining companies had news out today
Ergomed says sickle-cell drug enters proof-of-concept study
Ergomed’s partner, the Swedish firm Dilaforette, is hoping to recruit 70 sufferers that can be evaluated using the drug, which is called sevuparin.
Investments and investor services
Proactive news highlights including Fastjet, Active energy, KEFI, Arian Silver...
There was a lot of news from the small cap space today
Ergomed increases backing for Multikine cancer treatment
Multikine is designed to be a different type of therapy in the fight against cancer: one that appears to have the potential to work with the body's natural immune system in the fight against tumours.
Archive
Proactive (non-mining) news summary: Active Energy, Aggregated Micro, Globo, Learning Technologies .
The end of quarter is approaching so companies were rushing out end-June trading updates, leading to a very heavy news day.
UPDATE - Ergomed orders grow strongly as it weighs in with solid set of interims
As well as providing clinical services, the company is partnered on a number of drug candidates.
Investments and investor services
Tuesday's agenda: Wolseley to highlight strength of US economy
Wolseley and Boohoo.com lead the companies reporting on Tuesday...
Archive
Week Ahead: Sainsbury's to update on the trolley wars
Sainsbury is likely to report continued hard times for the grocers.
Investments and investor services
Proactive news highlights: Velocys, Globo, eg Solutions, Gemfields, Ergomed, Kibo Mining and more...
Oil and mining dominated the small cap headlines today
Ergomed named finalist at Scrip awards
Ergomed, which provides drug development services to the pharma sector, says its successful run is continuing with the firm being shortlisted for a leading industry award.
Four Exciting Companies to present in London on Thursday 17th September
The management from e-Therapeutics (LON:ETX), Ergomed (LON:ERGO), Tissue Regenix (LON:TRX) and TekCapital (LON:TEK) will be updating investors on current developments and future prospects.
Friday’s news highlights Ergomed, Avation, Mytrah, Tekcapital, Armadale, Rosslyn Data Technologies, ZincOx, Stellar Diamonds
Ergomed said a cancer drug it helped developed will undergo a second-round efficacy and safety assessment
Ergomed announces first patient has been recruited for insomnia study
The study is a Phase IIa clinical trial testing the efficacy, safety and tolerability profile of Lorediplon in adult patients with insomnia disorder.
Ergomed appoints familiar face as chief business officer
Ergomed's newly appointed executive director has been working as a consultant for the company for the last 10 year.
Ergomed says patient recruitment is complete for womb cancer study
"We believe that zoptarelin doxorubicin has the potential to provide a new treatment for women with endometrial cancer, and look forward to obtaining data and progressing this study with our co-development partner Aeterna Zentaris, " said M
Archive
Proactive news summary: Xtract Resources, Wolf Minerals, ValiRx, Trap Oil, Sula Iron & Gold ...
Lekoil was boosted by the chief executive topping up his holding but there was some grim news elsewhere from the oil sector.